What is the proper dosage and treatment plan for using Ural (Citrate) sachet for a patient with a urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ural Sachet (Citrate) is NOT an Antibiotic and Should NOT Be Used as Primary Treatment for UTI

Ural sachet contains citrate, which is a urinary alkalinizer used only for symptomatic relief of dysuria—it does not treat the underlying bacterial infection and must be combined with appropriate antibiotic therapy. 1

What Ural Sachet Actually Does

  • Ural is a urinary alkalinizer that raises urinary pH to approximately 7.0-7.6, which may provide symptomatic relief from burning during urination 1
  • It has NO antimicrobial activity and will not eradicate the causative bacteria 1
  • The citrate formulation is indicated for conditions requiring urinary alkalinization, not as a standalone UTI treatment 1

Proper Dosing of Ural (If Used for Symptom Relief Only)

Adult Dosing: 1

  • 3 to 6 teaspoonfuls (15 to 30 mL) diluted in 1 glass of water
  • Taken after meals and at bedtime
  • Typical regimen: 2-3 teaspoonfuls (10-15 mL) four times daily

Pediatric Dosing: 1

  • 1 to 3 teaspoonfuls (5 to 15 mL) diluted in 1/2 glass of water
  • Taken after meals and at bedtime

Actual UTI Treatment Requirements

For Uncomplicated Cystitis in Women:

First-line antibiotics (choose one): 2

  • Fosfomycin trometamol 3 g single dose (preferred for convenience and minimal resistance)
  • Nitrofurantoin 50-100 mg four times daily OR 100 mg twice daily for 5 days
  • Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days (only if local resistance <20%)

For Uncomplicated Cystitis in Men:

  • Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 7 days 2

For Uncomplicated Pyelonephritis:

Choose one of: 2

  • Ciprofloxacin 500-750 mg twice daily for 7 days (only if local resistance <10%)
  • Levofloxacin 750 mg once daily for 5 days
  • Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 14 days

For Complicated UTIs:

Empiric therapy for systemic symptoms: 3

  • Amoxicillin PLUS aminoglycoside (IV)
  • Second-generation cephalosporin PLUS aminoglycoside (IV)
  • Third-generation cephalosporin (IV)
  • Duration: 7-14 days (14 days for men when prostatitis cannot be excluded) 3

Critical Clinical Pitfalls

  • Never use Ural as monotherapy for UTI—this will allow the infection to progress, potentially leading to pyelonephritis, sepsis, and renal scarring 4, 5
  • Fluoroquinolones should only be used when local resistance is <10% and should be avoided in patients from urology departments or those who used fluoroquinolones in the last 6 months 3, 2
  • Nitrofurantoin should NOT be used for febrile UTIs or pyelonephritis as it does not achieve adequate tissue concentrations outside the urinary tract 3
  • Always obtain urine culture before starting antibiotics in complicated UTIs to guide definitive therapy 3
  • Asymptomatic bacteriuria should NOT be treated except in pregnancy and preschool children 4

Appropriate Use of Ural in UTI Management

Ural may be used as an adjunct for symptomatic relief ONLY while the patient is on appropriate antibiotic therapy 1. It should never delay or replace antimicrobial treatment. The alkalinization of urine may reduce dysuria but provides no therapeutic benefit against the infection itself 1.

References

Guideline

UTI Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Approach to urinary tract infections.

Indian journal of nephrology, 2009

Research

Diagnosis and management of urinary tract infection and pyelonephritis.

Emergency medicine clinics of North America, 2011

Related Questions

What is the best course of action for a patient with recurrent dysuria and flank pain, who was treated for a urinary tract infection (UTI) 10 days ago?
What is the first-line treatment for an uncomplicated urinary tract infection (UTI)?
What is the best initial treatment approach for a 75-year-old sexually active woman with scant clear white vaginal discharge and positive leukocyte esterase (LE) in the urine?
What is the first-line treatment for a patient presenting with symptoms of a urinary tract infection (UTI)?
What is the next best course of action for a 48-year-old female with recurrent urinary tract infections (UTIs), currently experiencing dysuria and frequency, with a recent urinalysis (UA) showing trace white blood cells (WBC), ketones, and occult blood, but no growth on culture, and who is currently taking topiramate (for seizures), citalopram (for depression), and lorazepam (as needed), and has been previously treated with cipro (ciprofloxacin) and Bactrim (trimethoprim/sulfamethoxazole)?
What is the approximate duration in seconds of an 11-beat run of ventricular tachycardia (vtach) in a patient with a heart rate of 150-180 beats per minute?
What could be causing my gastrointestinal symptoms, given my history of pulsatile tinnitus, balance problems, and pressure in the face and head, and the relief I experience in my stomach with high pressure?
What is the recommended treatment plan for a pediatric patient with spina bifida, considering their age and developmental stage?
What is the recommended protocol for tapering mannitol (osmotic diuretic) in patients with increased intracranial pressure (ICP)?
At what duration of sustained ventricular tachycardia (VTach) should intervention be considered in a patient with a history of structural heart disease?
What is the best management plan for a patient with progressing multilevel lumbar spondylosis, moderate to advanced disc space narrowing at L3-4, L4-5, and L5-S1, marrow edema, and moderate neural foraminal stenosis at L3-4 and L5-S1?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.